In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Zenith TX2 graft

This article was originally published in The Gray Sheet

Executive Summary

Cook projects first quarter 2008 U.S. launch of its Zenith TX2 thoracic aortic aneurysm endovascular graft following submission to FDA of the final PMA module, announced Aug. 7. The PMA includes data from the 230-patient STARZ-TX2 trial, which was presented at the Society for Vascular Surgery conference in Baltimore June 9. Zenith's TX2 is already available in Europe, Australia and New Zealand. Gore's TAG TAA device was approved in 2005, and Medtronic is seeking approval for its Talent TAA graft (1"The Gray Sheet" Jan. 1, 2006, In Brief)...

Related Content




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts